Company news
Jamjoom Pharmaceuticals Factory Co. (TADAWUL:4015) news
Jamjoom Pharmaceuticals Factory Co. news releases on 6ix. Latest, Jun 7, 2026: ZAWYA: Jamjoom Pharma signs MOU with the Ministry of Health in Saudi Arabia…
Press releases & updates
ZAWYA: Jamjoom Pharma signs MOU with the Ministry of Health in Saudi Arabia to develop healthcare talents
June 7, 2026
Jamjoom Pharma Signs Letter Of Credit And Short Term Loan Facilities By Its Joint Venture In Algeria
May 11, 2026
ZAWYA: Jamjoom Pharma signs agreement to acquire pharmaceutical manufacturing facility in Saudi Arabia from Pfizer
April 28, 2026
ZAWYA: PharmaZ Career Summit concludes
April 23, 2026
ZAWYA: Jamjoom Pharma and Caritas Egypt launch a strategic partnership to enhance eye health
April 22, 2026
ZAWYA: Jamjoom Pharma and Magrabi Health Group sign an MoU to enhance Ophthalmology services in Saudi Arabia
March 30, 2026
Jamjoom Pharma H2 Dividend SAR 2 /Share
February 24, 2026
ZAWYA-PRESSR: Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology
January 26, 2026
SNG: Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem
October 29, 2025
PRESSR: Lifera and Jamjoom Pharma launch strategic joint venture to power Saudi Arabia’s biopharma future
October 27, 2025
SNG: Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25
October 24, 2025
Jamjoom Pharma Q3 Profit SAR 106.67 Million
October 23, 2025
PRESSR: Jamjoom Pharma unveils new brand identity
October 4, 2025
PRESSR: Jamjoom Pharma unveils new brand identity to accelerate regional and global growth
October 2, 2025
PRESSR: Jamjoom Pharma and Iraqi Dermatology Society sign MoU to transform skin health awareness
September 25, 2025
SNG: Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
September 16, 2025
Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA
September 15, 2025
PRESSR: New agreement brings breakthrough dyslipidemia treatment to Saudi Arabia and MEA
July 30, 2025
Jamjoom Pharma H1 Dividend Per Share SAR 2.00
July 24, 2025
PRESSR: Jamjoom Pharma and the Emirates Dermatology Society join forces to launch “ECZPLORE” – A National Awareness Initiative to help families lead an Eczema-Friendly Life
July 7, 2025
Jamjoom Pharma Announces Board Recommendation To Buy-Back Its Shares
May 14, 2025
SNG: Saudi: Jamjoom Pharma logs $42mln net profits in Q1-25
April 30, 2025